IDH1 and central nervous system cancer: A statistically significant increase in the activity of this enzyme in the peritumoral zone in the event of an IDH1 mutation is consistent with the available data on the normalization of glucose metabolism in gliomas with an IDH1 mutation which leads to slower progression of the tumor [26].